title: Management of colon cancer in patients with cirrhosis: A review.
abstract: BACKGROUND
  The incidence of cirrhosis is increasing in parallel with that of hepatitis C and non-alcoholic steatohepatitis. Patients with colon cancer and liver cirrhosis constitute an important at-risk group. Many colorectal surgeons and oncologists are not familiar with the management of colon cancer in patients with cirrhosis. Here, we review the literature on the management and prognosis of patients with both colon cancer and cirrhosis.
  
  
  METHODS
  The MEDLINE, PubMed and the Cochrane Library electronic databases were systematically searched with appropriate keywords. Only publications in French or English were selected.
  
  
  CONCLUSIONS
  For most studies, the level of evidence is weak. Child A patients should probably be managed in the same way as general population, although they have an elevated risk of morbidity and a five-year survival rate of just 70%. Child B and C patients should be managed more cautiously, although no specific recommendations can be made at present. For colon surgery, laparotomy should be preferred in patients with cirrhosis. The role of adjuvant chemotherapy is unclear, since survival is strongly associated with the improvements in liver function. Oxaliplatin appears to be associated with an elevated post-chemotherapy morbidity rate in patients with portal hypertension.
authors.affiliation: Department of Digestive and Oncologic Surgery, Amiens University Hospital, Amiens, France; Jules Verne University of Picardie, Amiens, France; INSERM Unit 1088, University of Picardie, Amiens, France.
authors.forename: C
authors.initials: C
authors.lastname: Sabbagh
authors.affiliation: Department of Digestive and Oncologic Surgery, Amiens University Hospital, Amiens, France; Jules Verne University of Picardie, Amiens, France; Clinical Research Centre, Amiens University Hospital, Amiens, France.
authors.forename: C
authors.initials: C
authors.lastname: Cosse
authors.affiliation: Jules Verne University of Picardie, Amiens, France; Department of Oncology, Amiens University Hospital, Amiens, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Chauffert
authors.affiliation: Department of Gastroenterology, Amiens University Hospital, Amiens, France.
authors.forename: E
authors.initials: E
authors.lastname: Nguyen-Khac
authors.affiliation: Department of Gastroenterology, Amiens University Hospital, Amiens, France.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Joly
authors.affiliation: Department of Radiology, Amiens University Hospital, Amiens, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Yzet
authors.affiliation: Department of Digestive and Oncologic Surgery, Amiens University Hospital, Amiens, France; Jules Verne University of Picardie, Amiens, France; INSERM Unit EA4294, University of Picardie, Amiens, France. Electronic address: regimbeau.jean-marc@chu-amiens.fr.
authors.forename: J M
authors.initials: JM
authors.lastname: Regimbeau
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents
keywords: Cirrhosis; Colon cancer; Management; Oncological strategy